Gavin Wood
Directeur Financier/CFO chez ADAPTIMMUNE THERAPEUTICS PLC
Profil
Gavin Wood is currently the Director at Atlas Antibodies AB since 2023 and the Chief Financial Officer at Adaptimmune Therapeutics Plc since 2020.
Previously, he served as the Chief Financial Officer & Executive Director at Abcam Plc from 2016 to 2020.
Prior to that, he held the position of Chief Financial Officer & Director at eBioscience, Inc. He also served as the Chief Financial Officer & Executive Vice President at Affymetrix, Inc. from 2006 to 2016.
Additionally, he worked as a Controller at Unipart Group of Cos.
Ltd.
Mr. Wood completed his undergraduate degree at the University of Durham.
Postes actifs de Gavin Wood
Sociétés | Poste | Début |
---|---|---|
ADAPTIMMUNE THERAPEUTICS PLC | Directeur Financier/CFO | 01/04/2020 |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Directeur Financier/CFO | 01/04/2020 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 01/05/2023 |
Anciens postes connus de Gavin Wood
Sociétés | Poste | Fin |
---|---|---|
ABCAM PLC | Directeur Financier/CFO | 03/02/2020 |
AFFYMETRIX, INC. | Directeur Financier/CFO | 01/06/2016 |
Unipart Group of Cos. Ltd.
Unipart Group of Cos. Ltd. Miscellaneous Commercial ServicesCommercial Services Unipart Group of Cos. Ltd. engages in the provision of supply chain and logistics solutions. It serves the automotive, technology,retail, utilities, and rail industry. The company was founded on March 4, 1986 and headquartered in Cowley, the United kingdom. | Comptroller/Controller/Auditor | - |
eBioscience, Inc.
eBioscience, Inc. BiotechnologyHealth Technology eBioscience, Inc. manufactures staple research reagents. The company was founded in 1999 and is headquarter in Santa Clara, CA. | Directeur Financier/CFO | - |
Formation de Gavin Wood
University of Durham | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ABCAM PLC | Health Technology |
ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
Entreprise privées | 5 |
---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
eBioscience, Inc.
eBioscience, Inc. BiotechnologyHealth Technology eBioscience, Inc. manufactures staple research reagents. The company was founded in 1999 and is headquarter in Santa Clara, CA. | Health Technology |
Unipart Group of Cos. Ltd.
Unipart Group of Cos. Ltd. Miscellaneous Commercial ServicesCommercial Services Unipart Group of Cos. Ltd. engages in the provision of supply chain and logistics solutions. It serves the automotive, technology,retail, utilities, and rail industry. The company was founded on March 4, 1986 and headquartered in Cowley, the United kingdom. | Commercial Services |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Health Services |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |